HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antigenic structure of transmissible gastroenteritis virus. II. Domains in the peplomer glycoprotein.

Abstract
The antigenic structure of the peplomer glycoprotein E2 of the porcine transmissible gastroenteritis coronavirus (TGEV) was explored using a panel of 23 hybridoma antibodies (MAbs). The topography of the epitopes was established by means of a competition radioimmunoassay. Four main antigenic sites, termed A, B, C and D, were thus clearly delineated. Most of the neutralization-mediating determinants were found to cluster in the A-B area, which has been shown to be highly conserved among TGEV strains. Cooperative enhancement of binding to sites B and D was observed following attachment of MAbs relevant to site A. Additional epitopes were identified on E2 by MAbs that selectively recognized its intracellular precursor. Functional mapping was also performed using neutralization-resistant variants. Analysis of their reactivity confirmed part of the epitope linkages defined by the first approach. The overall lower frequency of such variants altered at site A suggested that some of the epitopes may play an essential function.
AuthorsB Delmas, J Gelfi, H Laude
JournalThe Journal of general virology (J Gen Virol) Vol. 67 ( Pt 7) Pg. 1405-18 (Jul 1986) ISSN: 0022-1317 [Print] England
PMID2425049 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Viral
  • Antigens, Viral
  • Epitopes
  • Glycoproteins
  • Viral Proteins
Topics
  • Antibodies, Monoclonal (immunology)
  • Antibodies, Viral (immunology)
  • Antigens, Viral (immunology)
  • Coronaviridae (immunology)
  • Epitopes (immunology)
  • Genetic Linkage
  • Glycoproteins (immunology)
  • Neutralization Tests
  • Radioimmunoassay
  • Transmissible gastroenteritis virus (immunology)
  • Viral Proteins (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: